Diseases Associated With Positive Regulation Of Er-Associated Ubiquitin-Dependent Protein Catabolic Process
| Disease |
|
Prostatic Neoplasms
|
|
Liver Cirrhosis, Experimental
|
|
Atrial Fibrillation
|
|
Breast Carcinoma
|
|
Hepatocellular Carcinoma
|
|
Carcinoma, Non-Small-Cell Lung
|
|
Carcinoma, Pancreatic Ductal
|
|
Squamous Cell Carcinoma
|
|
Cardiac Hypertrophy
|
|
Cholestasis
|
|
Dermatitis, Allergic Contact
|
|
Diabetes Mellitus, Experimental
|
|
Diabetic Nephropathy
|
|
Drug-Induced Liver Injury
|
|
Drug-Related Side Effects And Adverse Reactions
|
|
Emphysema
|
|
Encephalomyelitis, Autoimmune, Experimental
|
|
Endometrial Neoplasm
|
|
Esophageal Squamous Cell Carcinoma
|
|
Gastrointestinal Diseases
|
|
Open-Angle Glaucoma
|
|
Hyperglycemia
|
|
Hyperplasia
|
|
Hypertension
|
|
Keratosis
|
|
Kidney Disease
|
|
Lipodystrophy, Congenital Generalized, Type 3
|
|
Lipodystrophy, Familial Partial
|
|
Liver Cirrhosis
|
|
Liver Neoplasms
|
|
Necrosis
|
|
Neoplasm Invasiveness
|
|
Neoplasm Metastasis
|
|
Neurotoxicity Syndromes
|
|
Non-Alcoholic Fatty Liver Disease
|
|
Ovarian Neoplasms
|
|
Primary Ovarian Insufficiency
|
|
Pulmonary Fibrosis
|
|
Skin Neoplasms
|
|
Toxic Epidermal Necrolysis
|
|
Stomach Neoplasms
|
|
Vascular System Injuries
|
|
Acute Kidney Injury
|
|
Weight Gain
|
|
Acute Lung Injury
|
